2021
DOI: 10.1007/s12602-021-09846-9
|View full text |Cite
|
Sign up to set email alerts
|

Bifidobacterium longum subsp. longum 51A Attenuates Signs of Inflammation in a Murine Model of Food Allergy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 52 publications
0
8
0
Order By: Relevance
“…Oral administration of probiotic strains such as Lactobacillus and Bifidobacterium alleviated weight loss and reduced the levels of serum OVA-sIgE, intestinal Th2-type, and Th17-type cytokines. 24,25 The research is now focusing on the specific mechanism how probiotic strains alleviated FA. Probiotic strains could alleviate FA pathological symptoms by regulating the functionality of DC.…”
Section: Discussionmentioning
confidence: 99%
“…Oral administration of probiotic strains such as Lactobacillus and Bifidobacterium alleviated weight loss and reduced the levels of serum OVA-sIgE, intestinal Th2-type, and Th17-type cytokines. 24,25 The research is now focusing on the specific mechanism how probiotic strains alleviated FA. Probiotic strains could alleviate FA pathological symptoms by regulating the functionality of DC.…”
Section: Discussionmentioning
confidence: 99%
“…However, in some cases, the postbiotic does not work as well as the live bacterium, such as when inactivated Bifidobacterium longum subsp. longum 5 1A immunity produced beneficial effects in inflammation in a mouse model of food allergy [ 98 ]. This suggests that live bacteria have advantages that are unmatched by postbiotics.…”
Section: Postbiotics and Food Allergymentioning
confidence: 99%
“…Some groups were treated with B. longum 5 1A . The probiotic bacterium B. longum 5 1A , from the culture collection of the Laboratory of Biotherapeutic Agents at ICB/UFMG, was isolated from fecal samples of healthy children and was cultivated as previously described (Santos et al, 2021;Vieira et al, 2016b). Briefly, mice were treated by oral gavage of a single 100 μL dose of suspension containing 1x10 9 CFU/mL B. longum 5 1A , or sterile saline every 48h during the infection period (Vieira et al, 2016b).…”
Section: Mouse Hepatitis Virus-3 (Mhv-3) Infectionmentioning
confidence: 99%